<?xml version="1.0" encoding="UTF-8"?>
<ref id="bib7">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Cooper</surname>
    <given-names>P.J.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Chico</surname>
    <given-names>M.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Sandoval</surname>
    <given-names>C.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Espinel</surname>
    <given-names>I.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Guevara</surname>
    <given-names>A.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Levine</surname>
    <given-names>M.M.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Griffin</surname>
    <given-names>G.E.</given-names>
   </name>, and 
   <name name-style="western">
    <surname>Nutman</surname>
    <given-names>T.B.</given-names>
   </name>
  </person-group>
  <year>2001</year>
  <article-title>Human infection with Ascaris lumbricoides is associated with suppression of the interleukin-2 response to recombinant cholera toxin B subunit following vaccination with the live oral cholera vaccine CVD 103-HgR</article-title>. 
  <source>Infect. Immun</source>. 
  <volume>69</volume>:
  <fpage>1574</fpage>â€“
  <lpage>1580</lpage>. 
  <pub-id pub-id-type="doi">10.1128/IAI.69.3.1574-1580.2001</pub-id>
  <pub-id pub-id-type="pmid">11179329</pub-id>
 </mixed-citation>
</ref>
